Depression in prevalent maintenance hemodialysispatients
Main Article Content
Keywords
MHD; Depression; MADRS; AV fistula; Vascular access
Abstract
Background: Depression is a common mental health issue among patients on maintenance hemodialysis (MHD), significantly impacting their quality of life and overall prognosis. While prior studies have reported variable prevalence rates globally, data specific to MHD patients in our regional tertiary care setting remain limited. This study addresses this gap byevaluating prevalence, severity, and associated factors of depression, thereby supporting evidence-based health strategies in this at-risk population. Methods: This cross-sectional study evaluated the prevalence and severity of depression in 74 patients undergoing MHD at a tertiary care center in North India. The Montgomery-Åsberg Depression Rating Scale (MADRS) was used to assess the symptoms of depression. Results: The overall prevalence of depression was 59.5%. Among the participants 33.8% had mild depression, 23.0%had moderate depression, and 2.7% had severe depression. Patients dialyzed via tunneled hemodialysis catheters exhibited significantly higher rates of depression compared to those with arteriovenous fistulas (p < 0.05). Patients with a transplant prospect had lower rates of depression compared to those without (p < 0.05). Conclusions: Depression is highly prevalent in patients on MHD. This study highlights the need for routine depression screening and appropriate management in this vulnerable population to improve their overall well-being and treatment outcomes.
References
[2] Kovesdy CP. Epidemiology of chronic kidney disease: an update 2022. Kidney International Supplements. 2022; 12: 7–11.
[3] Rong J, Wang X, Cheng P, Li D, Zhao D. Global, regional and national burden of depressive disorders and attributable risk factors, from 1990 to 2021: results from the 2021 Global Burden of Disease study. British Journal of Psychiatry. 2025; 227: 688–697.
[4] Zhao J, Wu M, Zhang L, Han X, Wu J, Wang C. Higher levels of depression are associated with increased all-cause mortality in individuals with chronic kidney disease: a prospective study based on the NHANES database. Journal of Affective Disorders. 2025; 390: 119785.
[5] Wicke FS, Ernst M, Otten D, Werner A, Dreier M, Brähler E, et al. The association of depression and all-cause mortality: explanatory factors and the influence of gender. Journal of Affective Disorders. 2022; 303: 315–322.
[6] Fischer MJ, Streja E, Hsiung JT, Crowley ST, Kovesdy CP, Kalantar-Zadeh K, et al. Depression screening and clinical outcomes among adults initiating maintenance hemodialysis. Clinical Kidney Journal. 2021; 14: 2548–2555.
[7] Kubanek A, Renke M, Godlewska BR, Paul P, Przybylak M, Kowalska AS, et al. Screening for depression in chronic haemodialysis patients as a part of care in dialysis setting: a cross-sectional study. Frontiers in Psychiatry. 2024; 15: 1410252.
[8] Hockham C, Ghosh A, Agarwal A, Shah K, Woodward M, Jha V. Centre-level variation in the survival of patients receiving haemodialysis in India: findings from a nationwide private haemodialysis network. The Lancet Regional Health—Southeast Asia. 2024; 23: 100383.
[9] Mharapara P, Ahmed SB, Olson J, Schick-Makaroff K. Sex and gender characteristics of adults on hemodialysis experiencing depression and depressive symptoms: a scoping review. Canadian Journal of Kidney Health and Disease. 2025; 12: 20543581251378018.
[10] Shaikh M, Woodward M, John O, Bassi A, Jan S, Sahay M, et al. Utilization, costs, and outcomes for patients receiving publicly funded hemodialysis in India. Kidney International. 2018; 94: 440–445.
[11] Hecking M, Bieber BA, Ethier J, Kautzky-Willer A, Sunder-Plassmann G, Säemann MD, et al. Sex-specific differences in hemodialysis prevalence and practices and the male-to-female mortality rate: the Dialysis Outcomes and Practice Patterns Study (DOPPS). PLOS Medicine. 2014; 11: e1001750.
[12] Vijayan M, Radhakrishnan S, Abraham G, Mathew M, Sampathkumar K, Mancha NP. Diabetic kidney disease patients on hemodialysis: a retrospective survival analysis across different socioeconomic groups. Clinical Kidney Journal. 2016; 9: 833–838.
[13] Modi GK, Jha V. The incidence of end-stage renal disease in India: a population-based study. Kidney International. 2006; 70: 2131–2133.
[14] Bansal D, Kher V, Gupta KL, Banerjee D, Jha V. Haemodialysis vascular access: current practices amongst Indian nephrologists. The Journal of Vascular Access. 2018; 19: 172–176.
[15] Kumar V, Yadav AK, Sethi J, Ghosh A, Sahay M, Prasad N, et al. The Indian Chronic Kidney Disease (ICKD) study: baseline characteristics. Clinical Kidney Journal. 2021; 15: 60–69.
[16] Dare AJ, Fu SH, Patra J, Rodriguez PS, Thakur JS, Jha P; Million Death Study Collaborators. Renal failure deaths and their risk factors in India 2001-13: nationally representative estimates from the Million Death Study. The Lancet Global Health. 2017; 5: e89–e95.
[17] Sahay M, Ismal K, Vali PS. Hemodialysis at doorstep—“Hub-and-Spoke” model of dialysis in a developing country. Saudi Journal of Kidney Diseases and Transplantation. 2020; 31: 840–849.
[18] Paik JM, Zhuo M, York C, Tsacogianis T, Kim SC, Desai RJ. Medication burden and prescribing patterns in patients on hemodialysis in the USA, 2013–2017. American Journal of Nephrology. 2021; 52: 919–928.
[19] Chilcot J, Wellsted D, Da Silva-Gane M, Farrington K. Depression on dialysis. Nephron Clinical Practice. 2008; 108: c256–c264.
[20] Çora AR, Çelik E. Association between vascular access type and depression in hemodialysis patients. Hemodialysis International. 2023; 27: 296–300.
[21] Keser BN, Kirman UN, Kocaaslan C, Aydin E. The association between vascular access type and depressive symptoms in geriatric hemodialysis population. Vascular. 2020; 28: 390–395.
[22] Chen X, Chu NM, Basyal PS, Vihokrut W, Crews D, Brennan DC, et al. Depressive symptoms at kidney transplant evaluation and access to the kidney transplant waitlist. Kidney International Reports. 2022; 7: 1306–1317.
[23] Yuan C, Chang F, Zhai H, Du J, Lu D, Ma H, et al. Integrative approaches to depression in end-stage renal disease: insights into mechanisms, impacts, and pharmacological strategies. Frontiers in Pharmacology. 2025; 16: 1559038.
[24] Hedayati SS, Grambow SC, Szczech LA, Stechuchak KM, Allen AS, Bosworth HB. Physician-diagnosed depression as a correlate of hospitalizations in patients receiving long-term hemodialysis. American Journal of Kidney Diseases. 2005; 46: 642–649.
[25] Lopes AA, Albert JM, Young EW, Satayathum S, Pisoni RL, Andreucci VE, et al. Screening for depression in hemodialysis patients: associations with diagnosis, treatment, and outcomes in the DOPPS. Kidney International. 2004; 66: 2047–2053.
